[1]
SEESIN, T. et al. 2019. EVALUATION OF CEFOPERAZONE/SULBACTAM AND VITAMIN K USE IN PATIENTS WITH BACTERIAL INFECTIONS. International Journal of Applied Pharmaceutics. 11, 5 (Sep. 2019), 191–193. DOI:https://doi.org/10.22159/ijap.2019.v11s5.T0100.